 | • レポートコード：MRC2312MG08974 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、77ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥455,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥682,500 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の経皮避妊パッチ市場規模と予測を収録しています。・世界の経皮避妊パッチ市場：売上、2018年-2023年、2024年-2029年 ・世界の経皮避妊パッチ市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の経皮避妊パッチ市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「7日間交換」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 経皮避妊パッチのグローバル主要企業は、Gedeon Richter、 Mylan Pharmaceuticals、 Twirla、 Luye Pharma、 AbbVieなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、経皮避妊パッチのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の経皮避妊パッチ市場：タイプ別、2018年-2023年、2024年-2029年 世界の経皮避妊パッチ市場：タイプ別市場シェア、2022年 ・7日間交換、3日間交換 世界の経皮避妊パッチ市場：用途別、2018年-2023年、2024年-2029年 世界の経皮避妊パッチ市場：用途別市場シェア、2022年 ・オンライン販売、オフライン販売 世界の経皮避妊パッチ市場：地域・国別、2018年-2023年、2024年-2029年 世界の経皮避妊パッチ市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における経皮避妊パッチのグローバル売上、2018年-2023年 ・主要企業における経皮避妊パッチのグローバル売上シェア、2022年 ・主要企業における経皮避妊パッチのグローバル販売量、2018年-2023年 ・主要企業における経皮避妊パッチのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Gedeon Richter、 Mylan Pharmaceuticals、 Twirla、 Luye Pharma、 AbbVie ************************************************************* ・調査・分析レポートの概要 経皮避妊パッチ市場の定義 市場セグメント 世界の経皮避妊パッチ市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の経皮避妊パッチ市場規模 世界の経皮避妊パッチ市場規模：2022年 VS 2029年 世界の経皮避妊パッチ市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの経皮避妊パッチの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の経皮避妊パッチ製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：7日間交換、3日間交換 経皮避妊パッチのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：オンライン販売、オフライン販売 経皮避妊パッチの用途別グローバル売上・予測 ・地域別市場分析 地域別経皮避妊パッチ市場規模 2022年と2029年 地域別経皮避妊パッチ売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Gedeon Richter、 Mylan Pharmaceuticals、 Twirla、 Luye Pharma、 AbbVie ... |
This research report provides a comprehensive analysis of the Transdermal Contraceptive Patch market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Transdermal Contraceptive Patch market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Transdermal Contraceptive Patch, challenges faced by the industry, and potential opportunities for market players.
The global Transdermal Contraceptive Patch market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Transdermal Contraceptive Patch market presents opportunities for various stakeholders, including Online Sales, Offline Sales. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Transdermal Contraceptive Patch market. Additionally, the growing consumer demand present avenues for market expansion.
The global Transdermal Contraceptive Patch market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Transdermal Contraceptive Patch market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Transdermal Contraceptive Patch market.
Market Overview: The report provides a comprehensive overview of the Transdermal Contraceptive Patch market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Seven Days Replacement, Three Days Replacement), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Transdermal Contraceptive Patch market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Transdermal Contraceptive Patch market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Transdermal Contraceptive Patch market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Transdermal Contraceptive Patch market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Transdermal Contraceptive Patch market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Transdermal Contraceptive Patch market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Transdermal Contraceptive Patch, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Transdermal Contraceptive Patch market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Transdermal Contraceptive Patch market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Seven Days Replacement
Three Days Replacement
Market segment by Application
Online Sales
Offline Sales
Global Transdermal Contraceptive Patch Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Gedeon Richter
Mylan Pharmaceuticals
Twirla
Luye Pharma
AbbVie
Outline of Major Chapters:
Chapter 1: Introduces the definition of Transdermal Contraceptive Patch, market overview.
Chapter 2: Global Transdermal Contraceptive Patch market size in revenue and volume.
Chapter 3: Detailed analysis of Transdermal Contraceptive Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Transdermal Contraceptive Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Transdermal Contraceptive Patch capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Transdermal Contraceptive Patch Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Transdermal Contraceptive Patch Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Transdermal Contraceptive Patch Overall Market Size
2.1 Global Transdermal Contraceptive Patch Market Size: 2022 VS 2029
2.2 Global Transdermal Contraceptive Patch Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Transdermal Contraceptive Patch Sales: 2018-2029
3 Company Landscape
3.1 Top Transdermal Contraceptive Patch Players in Global Market
3.2 Top Global Transdermal Contraceptive Patch Companies Ranked by Revenue
3.3 Global Transdermal Contraceptive Patch Revenue by Companies
3.4 Global Transdermal Contraceptive Patch Sales by Companies
3.5 Global Transdermal Contraceptive Patch Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Transdermal Contraceptive Patch Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Transdermal Contraceptive Patch Product Type
3.8 Tier 1, Tier 2 and Tier 3 Transdermal Contraceptive Patch Players in Global Market
3.8.1 List of Global Tier 1 Transdermal Contraceptive Patch Companies
3.8.2 List of Global Tier 2 and Tier 3 Transdermal Contraceptive Patch Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Transdermal Contraceptive Patch Market Size Markets, 2022 & 2029
4.1.2 Seven Days Replacement
4.1.3 Three Days Replacement
4.2 By Type – Global Transdermal Contraceptive Patch Revenue & Forecasts
4.2.1 By Type – Global Transdermal Contraceptive Patch Revenue, 2018-2023
4.2.2 By Type – Global Transdermal Contraceptive Patch Revenue, 2024-2029
4.2.3 By Type – Global Transdermal Contraceptive Patch Revenue Market Share, 2018-2029
4.3 By Type – Global Transdermal Contraceptive Patch Sales & Forecasts
4.3.1 By Type – Global Transdermal Contraceptive Patch Sales, 2018-2023
4.3.2 By Type – Global Transdermal Contraceptive Patch Sales, 2024-2029
4.3.3 By Type – Global Transdermal Contraceptive Patch Sales Market Share, 2018-2029
4.4 By Type – Global Transdermal Contraceptive Patch Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Transdermal Contraceptive Patch Market Size, 2022 & 2029
5.1.2 Online Sales
5.1.3 Offline Sales
5.2 By Application – Global Transdermal Contraceptive Patch Revenue & Forecasts
5.2.1 By Application – Global Transdermal Contraceptive Patch Revenue, 2018-2023
5.2.2 By Application – Global Transdermal Contraceptive Patch Revenue, 2024-2029
5.2.3 By Application – Global Transdermal Contraceptive Patch Revenue Market Share, 2018-2029
5.3 By Application – Global Transdermal Contraceptive Patch Sales & Forecasts
5.3.1 By Application – Global Transdermal Contraceptive Patch Sales, 2018-2023
5.3.2 By Application – Global Transdermal Contraceptive Patch Sales, 2024-2029
5.3.3 By Application – Global Transdermal Contraceptive Patch Sales Market Share, 2018-2029
5.4 By Application – Global Transdermal Contraceptive Patch Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Transdermal Contraceptive Patch Market Size, 2022 & 2029
6.2 By Region – Global Transdermal Contraceptive Patch Revenue & Forecasts
6.2.1 By Region – Global Transdermal Contraceptive Patch Revenue, 2018-2023
6.2.2 By Region – Global Transdermal Contraceptive Patch Revenue, 2024-2029
6.2.3 By Region – Global Transdermal Contraceptive Patch Revenue Market Share, 2018-2029
6.3 By Region – Global Transdermal Contraceptive Patch Sales & Forecasts
6.3.1 By Region – Global Transdermal Contraceptive Patch Sales, 2018-2023
6.3.2 By Region – Global Transdermal Contraceptive Patch Sales, 2024-2029
6.3.3 By Region – Global Transdermal Contraceptive Patch Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Transdermal Contraceptive Patch Revenue, 2018-2029
6.4.2 By Country – North America Transdermal Contraceptive Patch Sales, 2018-2029
6.4.3 US Transdermal Contraceptive Patch Market Size, 2018-2029
6.4.4 Canada Transdermal Contraceptive Patch Market Size, 2018-2029
6.4.5 Mexico Transdermal Contraceptive Patch Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Transdermal Contraceptive Patch Revenue, 2018-2029
6.5.2 By Country – Europe Transdermal Contraceptive Patch Sales, 2018-2029
6.5.3 Germany Transdermal Contraceptive Patch Market Size, 2018-2029
6.5.4 France Transdermal Contraceptive Patch Market Size, 2018-2029
6.5.5 U.K. Transdermal Contraceptive Patch Market Size, 2018-2029
6.5.6 Italy Transdermal Contraceptive Patch Market Size, 2018-2029
6.5.7 Russia Transdermal Contraceptive Patch Market Size, 2018-2029
6.5.8 Nordic Countries Transdermal Contraceptive Patch Market Size, 2018-2029
6.5.9 Benelux Transdermal Contraceptive Patch Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Transdermal Contraceptive Patch Revenue, 2018-2029
6.6.2 By Region – Asia Transdermal Contraceptive Patch Sales, 2018-2029
6.6.3 China Transdermal Contraceptive Patch Market Size, 2018-2029
6.6.4 Japan Transdermal Contraceptive Patch Market Size, 2018-2029
6.6.5 South Korea Transdermal Contraceptive Patch Market Size, 2018-2029
6.6.6 Southeast Asia Transdermal Contraceptive Patch Market Size, 2018-2029
6.6.7 India Transdermal Contraceptive Patch Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Transdermal Contraceptive Patch Revenue, 2018-2029
6.7.2 By Country – South America Transdermal Contraceptive Patch Sales, 2018-2029
6.7.3 Brazil Transdermal Contraceptive Patch Market Size, 2018-2029
6.7.4 Argentina Transdermal Contraceptive Patch Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Transdermal Contraceptive Patch Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Transdermal Contraceptive Patch Sales, 2018-2029
6.8.3 Turkey Transdermal Contraceptive Patch Market Size, 2018-2029
6.8.4 Israel Transdermal Contraceptive Patch Market Size, 2018-2029
6.8.5 Saudi Arabia Transdermal Contraceptive Patch Market Size, 2018-2029
6.8.6 UAE Transdermal Contraceptive Patch Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Gedeon Richter
7.1.1 Gedeon Richter Company Summary
7.1.2 Gedeon Richter Business Overview
7.1.3 Gedeon Richter Transdermal Contraceptive Patch Major Product Offerings
7.1.4 Gedeon Richter Transdermal Contraceptive Patch Sales and Revenue in Global (2018-2023)
7.1.5 Gedeon Richter Key News & Latest Developments
7.2 Mylan Pharmaceuticals
7.2.1 Mylan Pharmaceuticals Company Summary
7.2.2 Mylan Pharmaceuticals Business Overview
7.2.3 Mylan Pharmaceuticals Transdermal Contraceptive Patch Major Product Offerings
7.2.4 Mylan Pharmaceuticals Transdermal Contraceptive Patch Sales and Revenue in Global (2018-2023)
7.2.5 Mylan Pharmaceuticals Key News & Latest Developments
7.3 Twirla
7.3.1 Twirla Company Summary
7.3.2 Twirla Business Overview
7.3.3 Twirla Transdermal Contraceptive Patch Major Product Offerings
7.3.4 Twirla Transdermal Contraceptive Patch Sales and Revenue in Global (2018-2023)
7.3.5 Twirla Key News & Latest Developments
7.4 Luye Pharma
7.4.1 Luye Pharma Company Summary
7.4.2 Luye Pharma Business Overview
7.4.3 Luye Pharma Transdermal Contraceptive Patch Major Product Offerings
7.4.4 Luye Pharma Transdermal Contraceptive Patch Sales and Revenue in Global (2018-2023)
7.4.5 Luye Pharma Key News & Latest Developments
7.5 AbbVie
7.5.1 AbbVie Company Summary
7.5.2 AbbVie Business Overview
7.5.3 AbbVie Transdermal Contraceptive Patch Major Product Offerings
7.5.4 AbbVie Transdermal Contraceptive Patch Sales and Revenue in Global (2018-2023)
7.5.5 AbbVie Key News & Latest Developments
8 Global Transdermal Contraceptive Patch Production Capacity, Analysis
8.1 Global Transdermal Contraceptive Patch Production Capacity, 2018-2029
8.2 Transdermal Contraceptive Patch Production Capacity of Key Manufacturers in Global Market
8.3 Global Transdermal Contraceptive Patch Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Transdermal Contraceptive Patch Supply Chain Analysis
10.1 Transdermal Contraceptive Patch Industry Value Chain
10.2 Transdermal Contraceptive Patch Upstream Market
10.3 Transdermal Contraceptive Patch Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Transdermal Contraceptive Patch Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer